1JS.F

Healthcare Drug Manufacturers - Specialty & Generic

Shield Therapeutics plc

€0.06

-0.00 -4.65% today

Price History

Not enough data

Key Stats

Market Cap

66.06M

Avg Volume

3,259

EPS

-€0.01

52W High

€0.15

52W Low

€0.03

Div. Yield

0.0%

Valuation

P/B Ratio

-4.40

P/S Ratio

1.13

EV/EBITDA

-18.59

EV/Revenue

1.41

Margins

Gross Margin 52.1%

Operating Margin 0.7%

Net Margin (17.7%)

EBITDA Margin (7.6%)

Growth & Returns

Revenue Growth (YoY)

41.6%

Return on Assets

(4.4%)

Liquidity & Leverage

Current Ratio

0.75

Quick Ratio

0.55

Total Cash

8.35M

Total Debt

24.90M

About

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru (ferric maltol), a non-salt based oral therapy for patients to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, United Kingdom.